Xetoheal-D Tablet is a combination pharmaceutical formulation containing Trypsin 48 mg, Bromelain 90 mg, Rutoside 100 mg, and Diclofenac 50 mg, designed to provide effective anti-inflammatory, analgesic, and fibrinolytic action. Trypsin and Bromelain are proteolytic enzymes that facilitate the breakdown of proteins and promote the reduction of edema and inflammation by enhancing the absorption of inflammatory exudates. Rutoside, a bioflavonoid, exhibits antioxidant properties and strengthens capillary walls, thereby improving microcirculation and reducing capillary permeability. Diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), inhibits cyclooxygenase enzymes, leading to decreased synthesis of prostaglandins, which are mediators of pain and inflammation. The synergistic effect of these components makes Xetoheal-D Tablet particularly useful in the management of acute musculoskeletal disorders, post-traumatic inflammation, postoperative swelling, and pain relief. It is indicated for conditions such as sprains, strains, contusions, and arthritis where inflammation and pain are predominant symptoms. The tablet should be used under medical supervision, considering contraindications such as hypersensitivity to NSAIDs, active gastrointestinal ulcers, and bleeding disorders. Adverse effects may include gastrointestinal discomfort, allergic reactions, or photosensitivity. Xetoheal-D offers a comprehensive approach to inflammation and pain management by combining enzymatic and pharmacological therapies.